Literature DB >> 16911610

Developments in pharmacological therapy for the overactive bladder.

Christopher R Chapple1, E Ann Gormley.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16911610     DOI： 10.1111/j.1464-410X.2006.06381.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  4 in total

1.  Economic evaluation of sacral neuromodulation in overactive bladder: A Canadian perspective.

Authors:  Magdy M Hassouna; Hamid Sadri
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  The potential of hormones and selective oestrogen receptor modulators in preventing voiding dysfunction in rats.

Authors:  Kavirach Tantiwongse; Thomas M Fandel; Guifang Wang; Benjamin N Breyer; Thomas J Walsh; Anthony J Bella; Tom F Lue
Journal:  BJU Int       Date:  2008-07-01       Impact factor: 5.588

Review 3.  Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review.

Authors:  Zara Khizer; Amina Sadia; Raman Sharma; Samia Farhaj; Jorabar Singh Nirwan; Pratibha G Kakadia; Talib Hussain; Abid Mehmood Yousaf; Yasser Shahzad; Barbara R Conway; Muhammad Usman Ghori
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-26

4.  Radiographic Position of the Electrode as a Predictor of the Outcome of InterStim Therapy.

Authors:  Abdullah Ahmed Gahzi; Mai Ahmed Banakhar; Dean S Elterman; Magdy Hassouna
Journal:  Int Neurourol J       Date:  2017-12-31       Impact factor: 2.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.